ASBPW

Aspire Biopharma Warrant
ASBPW

29 hedge funds and large institutions have $277K invested in Aspire Biopharma Warrant in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

1.13% less ownership

Funds ownership: 32.05% → 30.92% (-1.1%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$659
2
+$616

Top Sellers

1
-$4.5K
2
-$3.28K
3
-$1.73K
4
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$15
5
FTUS
Flow Traders U.S.
New York
-$10
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
26
Crossingbridge Advisors
New York
$822
OAC
27
OMERS Administration Corp
Ontario, Canada
$412
BPA
28
Beacon Pointe Advisors
California
$330
Nomura Holdings
29
Nomura Holdings
Japan
–
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
–
FTUS
31
Flow Traders U.S.
New York
–
1
2